VA
AMED

Vident Advisory’s Amedisys AMED Stock Holding History

Vident Advisory’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,276
Closed -$702K – 1446
2024
Q3 		$702K Buy
7,276
+1,835
+34% +$179K 0.02% 778
2024
Q2 		$499K Sell
5,441
-2,975
-35% -$276K 0.01% 878
2024
Q1 		$776K Buy
8,416
+1,882
+29% +$176K 0.02% 664
2023
Q4 		$621K Buy
+6,534
New +$610K 0.02% 701

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Vident Advisory's AMED Position: Q4 2024 in Review

Vident Advisory sold out of Amedisys (AMED) in Q4 2024, closing a stake of 7,276 shares — an estimated $702K sold.

Vident Advisory first reported a position in AMED in Q4 2023 and held it in 4 quarters. The position peaked at $776K in Q1 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Vident Advisory reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Vident Advisory sold 7,276 Amedisys shares in Q4 2024, an estimated $702K.
  • Vident Advisory first reported a position in Amedisys in Q4 2023 and held it in 4 quarters.
  • Vident Advisory's Amedisys position peaked at $776K in Q1 2024.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Vident Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.